Inventor · disambiguated record
Dagmar Ringe
Also filed as: RINGE DAGMAR
5 granted patents·7 pending applications·10 citations·filing 2003–2025
72Inventor score
Top patents by PatentIndex Score
12 records- 0177US11332504B2Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1UNIV BRANDEIS·Filed 2020·Granted May 17, 2022·1 cites·7 claims
- 0274US12275764B2Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2UNIV BRANDEIS·Filed 2022·Granted Apr 15, 2025·0 cites·16 claims
- 0372US9116157B2Ice-cleaved alpha-synuclein as a biomarkerRINGE DAGMAR·Filed 2011·Granted Aug 25, 2015·7 cites·15 claims
- 0470US10533038B2Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotideUNIV BRANDEIS·Filed 2013·Granted Jan 14, 2020·2 cites·3 claims
- 0569US2025163114A1Treatment of amyotrophic lateral sclerosisUNIV BRANDEIS·Filed 2025·Application pending·0 cites
- 0651US2004148105A1Computational method for predicting protein interaction sitesUNIV NORTHEASTERN·Filed 2003·Application pending·0 cites
- 0750US8609649B2Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseasesAGAR JEFFREY N·Filed 2008·Granted Dec 17, 2013·0 cites·9 claims
- 0843US2013289022A1Tetrameric alpha-synuclein and use thereofRINGE DAGMAR·Filed 2011·Application pending·0 cites
- 0943US2013309690A1Tetrameric alpha-synuclein as biomarkersRINGE DAGMAR·Filed 2011·Application pending·0 cites
- 1042US2014288145A1Treatment of amyloidosis by compounds that regulate retromer stabilizationUNIV BRANDEIS·Filed 2012·Application pending·0 cites
- 1135US2015361063A1Treatment of amyloidosis by compounds that regulate retromer stabilizationUNIV BRANDEIS·Filed 2015·Application pending·0 cites
- 1234US2016143985A1Ice-cleaved alpha-synuclein as a biomarkerUNIV BRANDEIS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dagmar Ringe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →